FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Chappuis

Research Profile

Disorders

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Switzerland

Living Beings

Jews

Co-author Network

Publications

TOP 3
Helena M Verkooijen; Georges Vlastos; M Usel; Simone Benhamou; Christine Bouchardy; Pierre O Chappuis; Kamila Czene; Mikael Hartman; Isabelle Neyroud-Caspar; Elisabetta Rapiti
Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics.
M Genevay; Pierre Hutter; P R Benusiglio; Pierre O Chappuis
[Lynch syndrome: when pathologist and clinician have the opportunity to reduce the risk of developing cancer].
Christine Bouchardy; Simone Benhamou; Gérald Fioretta; Helena M Verkooijen; Pierre O Chappuis; Isabelle Neyroud-Caspar; Monica Castiglione; vincent vinh-hung; Georges Vlastos; Elisabetta Rapiti
Risk of second breast cancer according to estrogen receptor status and family history.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Chappuis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Helena M Verkooijen; Georges Vlastos; M Usel; Simone Benhamou; Christine Bouchardy; Pierre O Chappuis; Kamila Czene; Mikael Hartman; Isabelle Neyroud-Caspar; Elisabetta Rapiti
Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics.
International journal of cancer. Journal international du cancer 2012;130(9):2103-10.
2011: M Genevay; Pierre Hutter; P R Benusiglio; Pierre O Chappuis
[Lynch syndrome: when pathologist and clinician have the opportunity to reduce the risk of developing cancer].
Revue médicale suisse 2011;7(303):1502-6.
2011: Christine Bouchardy; Simone Benhamou; Gérald Fioretta; Helena M Verkooijen; Pierre O Chappuis; Isabelle Neyroud-Caspar; Monica Castiglione; vincent vinh-hung; Georges Vlastos; Elisabetta Rapiti
Risk of second breast cancer according to estrogen receptor status and family history.
Breast cancer research and treatment 2011;127(1):233-41.
2010: Carole Deglise; Christine Bouchardy; Mafalda Burri; M Usel; Isabelle Neyroud-Caspar; Georges Vlastos; Pierre O Chappuis; Michela Ceschi; Silvia Ess; Monica Castiglione; Elisabetta Rapiti; Helena M Verkooijen
Impact of obesity on diagnosis and treatment of breast cancer.
Breast cancer research and treatment 2010;120(1):185-93.
2009: Helena M Verkooijen; Elisabetta Rapiti; Gérald Fioretta; V Vinh-Hung; J Keller; S Benhamou; Georges Vlastos; Pierre O Chappuis; Christine Bouchardy
Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups.
Cancer causes & control : CCC 2009;20(9):1689-96.
2009: David J Novak; Nelly Sabbaghian; Philippe Maillet; Pierre O Chappuis; William D Foulkes; Marc Tischkowitz
Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.
Breast cancer research and treatment 2009;117(2):453-9.
2009: A Merglen; Helena M Verkooijen; Gérald Fioretta; Isabelle Neyroud-Caspar; V Vinh-Hung; Georges Vlastos; Pierre O Chappuis; M Castiglione; Elisabetta Rapiti; Christine Bouchardy
Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(5):857-61.
2008: Christine Bouchardy; Sarah Fernandez; Arnaud Merglen; M Usel; Gérald Fioretta; Elisabetta Rapiti; Hyma Schubert; Marie-Françoise Pelte; Pierre O Chappuis; Georges Vlastos
Increased risk of second cancer among patients with ovarian borderline tumors.
Gynecologic oncology 2008;109(2):210-4.
2008: Helena M Verkooijen; Gérald Fioretta; Elisabetta Rapiti; Georges Vlastos; Isabelle Neyroud-Caspar; Pierre O Chappuis; Christine Bouchardy
Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based study.
International journal of cancer. Journal international du cancer 2008;122(5):1114-7.
2007: Helena M Verkooijen; Vanessa Chatelain; Gérald Fioretta; Georges Vlastos; Elisabetta Rapiti; André-Pascal Sappino; Christine Bouchardy; Pierre O Chappuis
Survival after bilateral breast cancer: results from a population-based study.
Breast cancer research and treatment 2007;105(3):347-57.
2007: Christine Bouchardy; Gérald Fioretta; Helena M Verkooijen; Georges Vlastos; Peter Schaefer; J-F Delaloye; Isabelle Neyroud-Caspar; S Balmer Majno; Yves Wespi; M Forni; Pierre O Chappuis; André-Pascal Sappino; Elisabetta Rapiti
Recent increase of breast cancer incidence among women under the age of forty.
British journal of cancer 2007;96(11):1743-6.
2006: Philippe Maillet; Pierre O Chappuis; Mary Khoshbeen-Boudal; Véronique Sciretta; André-Pascal Sappino
Twenty-three novel BRCA1 and BRCA2 sequence variations identified in a cohort of Swiss breast and ovarian cancer families.
Cancer genetics and cytogenetics 2006;169(1):62-8.
2006: Elisabetta Rapiti; Helena M Verkooijen; Georges Vlastos; Gérald Fioretta; Isabelle Neyroud-Caspar; André-Pascal Sappino; Pierre O Chappuis; Christine Bouchardy
Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2743-9.
2006: Pierre O Chappuis; Pierre Hutter
[Colorectal cancer: a risk-adapted screening and the role of the physician in the prevention of this cancer].
Revue médicale suisse 2006;2(66):1314, 1316, 1318-23.
2006: Anna Marie Russell; Jian Zhang; Judith Luz; Pierre Hutter; Pierre O Chappuis; Claudine Rey Berthod; Philippe Maillet; Hansjakob Mueller; Karl Heinimann
Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.
International journal of cancer. Journal international du cancer 2006;118(8):1937-40.
2006: Helena M Verkooijen; Pierre O Chappuis; Elisabetta Rapiti; Georges Vlastos; Gérald Fioretta; S Sarp; André-Pascal Sappino; H Schubert; Christine Bouchardy
Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study.
British journal of cancer 2006;94(2):231-8.
2005: Jarle Arnes; Jean-Sebastien Brunet; Ingunn M Stefansson; Louis R Bégin; Nora Wong; Pierre O Chappuis; Lars A Akslen; William D Foulkes
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4003-11.
2005: Pierre O Chappuis
[Plea for the family history...in the area of molecular oncology].
Revue médicale suisse 2005;1(20):1368-71, 1373.
2005: Pierre O Chappuis; E Donato; John R Goffin; Nora Wong; Louis R Bégin; Linda Kapusta; Jean-Sebastien Brunet; P Porter; William D Foulkes
Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):735-42.
2004: William D Foulkes; Jean-Sebastien Brunet; Ingunn M Stefansson; Oddbjørn Straume; Pierre O Chappuis; Louis R Bégin; Nancy Hamel; John R Goffin; Nora Wong; Michel Trudel; Linda Kapusta; Peggy Porter; Lars A Akslen
The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.
Cancer research 2004;64(3):830-5.
2004: Helena M Verkooijen; Gérald Fioretta; Pierre O Chappuis; Georges Vlastos; André-Pascal Sappino; S Benhamou; Christine Bouchardy
Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):350-3.
2004: Mark Robson; Pierre O Chappuis; Jaya M Satagopan; Nora Wong; Jeff Boyd; John R Goffin; Clifford Hudis; David Roberge; Larry Norton; Louis R Bégin; Kenneth Offit; William D Foulkes
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Breast cancer research : BCR 2004;6(1):R8-R17.
2003: William D Foulkes; Kelly A Metcalfe; Wedad M Hanna; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Olufunmilayo I Olopade; Barbara Weber; Jane McLennan; Ivo A Olivotto; Ping Sun; Pierre O Chappuis; Louis R Bégin; Jean-Sebastien Brunet; Steven A Narod
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma.
Cancer 2003;98(8):1569-77.
2003: William D Foulkes; Ingunn M Stefansson; Pierre O Chappuis; Louis R Bégin; John R Goffin; Nora Wong; Michel Trudel; Lars A Akslen
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
Journal of the National Cancer Institute 2003;95(19):1482-5.
2003: John R Goffin; Oddbjørn Straume; Pierre O Chappuis; Jean-Sebastien Brunet; Louis R Bégin; Nancy Hamel; Nora Wong; Lars A Akslen; William D Foulkes
Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer.
British journal of cancer 2003;89(6):1031-4.
2003: John R Goffin; Pierre O Chappuis; Louis R Bégin; Nora Wong; Jean-Sebastien Brunet; Nancy Hamel; Ann-Josée Paradis; Jeff Boyd; William D Foulkes
Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.
Cancer 2003;97(3):527-36.
2002: Oddbjørn Straume; Pierre O Chappuis; Helga B Salvesen; Ole Johan Halvorsen; Svein A Haukaas; John R Goffin; Louis R Bégin; William D Foulkes; Lars A Akslen
Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.
Cancer research 2002;62(23):6808-11.
2002: William D Foulkes; John R Goffin; Jean-Sebastien Brunet; Louis R Bégin; Nora Wong; Pierre O Chappuis
Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
Journal of the National Cancer Institute 2002;94(19):1504-6.
2002: Philippe Maillet; Hervé Bonnefoi; G Vaudan-Vutskits; B Pajk; Tanja Cufer; W D Foulkes; Pierre O Chappuis; André-Pascal Sappino
Constitutional alterations of the ATM gene in early onset sporadic breast cancer.
Journal of medical genetics 2002;39(10):751-3.
2002: Pierre O Chappuis; John R Goffin; Nora Wong; C Perret; P Ghadirian; P N Tonin; William D Foulkes
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer.
Journal of medical genetics 2002;39(8):608-10.
2002: William D Foulkes; Jean-Sebastien Brunet; Nora Wong; John R Goffin; Pierre O Chappuis
Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study.
Journal of medical genetics 2002;39(6):407-9.
2002: Pierre O Chappuis; William D Foulkes
Risk assessment & genetic testing.
Cancer treatment and research 2002;107():29-59.
2001: Pierre Hutter; Claudine Rey-Berthod; Pierre O Chappuis; Alexia Couturier; V Membrez; A Murphy; F Joris; D F Schorderet; Celia Delozier-Blanchet; claudio soravia
Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis.
Human mutation 2001;18(6):550.
2001: John R Goffin; Pierre O Chappuis; Nora Wong; William D Foulkes
Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
Journal of the National Cancer Institute 2001;93(22):1754-5.
2001: William D Foulkes; Joseph D Rosenblatt; Pierre O Chappuis
The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.
Journal of mammary gland biology and neoplasia 2001;6(4):453-65.
2001: Pierre O Chappuis; Nancy Hamel; Ann-Josée Paradis; Jean Deschênes; André Robidoux; C Potvin; J Cantin; Patricia N Tonin; Parviz Ghadirian; William D Foulkes
Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.
Clinical genetics 2001;59(6):418-23.
2001: Marc S Greenblatt; Pierre O Chappuis; Jeffrey P Bond; Nancy Hamel; William D Foulkes
TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.
Cancer research 2001;61(10):4092-7.
2001: Pierre O Chappuis; B Dieterich; V Sciretta; C Lohse; Hervé Bonnefoi; S Remadi; André-Pascal Sappino
Functional evaluation of plasmin formation in primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2731-8.
2001: Pierre O Chappuis; Nancy Hamel; Ann-Josée Paradis; Jean Deschênes; Patricia N Tonin; Parviz Ghadirian; William D Foulkes
Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
Journal of the National Cancer Institute 2001;93(2):152-4.
2000: Pierre O Chappuis; Linda Kapusta; Louis R Bégin; Nora Wong; Jean-Sebastien Brunet; Steven A Narod; Joyce M Slingerland; William D Foulkes
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(24):4045-52.
2000: Philippe Maillet; Pierre O Chappuis; G Vaudan; Zuzana Dobbie; H Müller; Pierre Hutter; André-Pascal Sappino
A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer.
International journal of cancer. Journal international du cancer 2000;88(6):928-31.
2000: Pierre O Chappuis; V Nethercot; William D Foulkes
Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.
Seminars in surgical oncology 2000;18(4):287-95.
2000: Pierre O Chappuis; Jean Deschênes; W D Foulkes
Long-term outcome of invasive breast cancer.
Lancet 2000;355(9214):1551; author reply 1552-3.
2000: William D Foulkes; Pierre O Chappuis; Nora Wong; Jean-Sebastien Brunet; Danny Vesprini; F Rozen; Ziqiang Yuan; MN Pollak; G Kuperstein; Steven A Narod; Louis R Bégin
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):307-13.
1999: Pierre O Chappuis; A Estreicher; B Dieterich; Hervé Bonnefoi; M Otter; André-Pascal Sappino; Richard D Iggo
Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assay.
International journal of cancer. Journal international du cancer 1999;84(6):587-93.
1999: Pierre O Chappuis; Joseph D Rosenblatt; William D Foulkes
The influence of familial and hereditary factors on the prognosis of breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(10):1163-70.
1999: Karl Heinimann; RJ Scott; Pierre O Chappuis; W Weber; Hansjakob Müller; Zuzana Dobbie; Pierre Hutter
N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers.
Cancer research 1999;59(13):3038-40.
1999: Philippe Maillet; G Vaudan; Pierre O Chappuis; André-Pascal Sappino
PCR-mediated detection of a polymorphism in the ATM gene.
Molecular and cellular probes 1999;13(1):67-9.
1999: Corinne Andreutti-Zaugg; Alexia Couturier; Pierre O Chappuis; Pierre Hutter
Detection of protein truncating mutations in exons 1-14 of the APC gene using an in vivo fusion protein assay. Mutations in brief no. 214. Online.
Human mutation 1999;13(2):170-1.
1998: Pierre Hutter; Alexia Couturier; V Membrez; F Joris; André-Pascal Sappino; Pierre O Chappuis
Excess of hMLH1 germline mutations in Swiss families with hereditary non-polyposis colorectal cancer.
International journal of cancer. Journal international du cancer 1998;78(6):680-4.
1995: Pierre O Chappuis; André-Pascal Sappino
Update: lymphoid neoplasms--molecular characterizations of non-Hodgkin's lymphomas: impact on patient management.
Seminars in hematology 1995;32(3):237-41.